| Literature DB >> 33068269 |
Takako Nomura1, Asahiro Morishita2, Joji Tani2, Kei Takuma2, Mai Nakahara2, Kyoko Oura2, Tomoko Tadokoro2, Kiyoyuki Kobayashi2, Koji Fujita2, Shima Mimura2, Hideki Kobara2, Kunihiko Tsutsui2, Takayuki Sanomura3, Yoshihiro Nishiyama3, Emi Ibuki4, Reiji Haba4, Teppei Sakamoto5, Hirohito Yoneyama6, Takashi Himoto7, Tsutomu Masaki2.
Abstract
The granulocyte colony-stimulating factor (G-CSF) is a glycoprotein that stimulates cell proliferation and differentiation of precursor cells in the bone marrow. Several cases of G-CSF-producing malignant tumors in various organs have been reported, but there are only nine cases of G-CSF-producing hepatocellular carcinoma (HCC) reported in the English literature. G-CSF-producing tumors grow rapidly and have a high probability of distant metastases; thus, they generally have a poor prognosis. Given that the mechanism of the carcinogenesis of G-CSF-producing HCC remains unclear, an efficient treatment strategy also remains to be elucidated. We report herein a case of G-CSF-producing HCC accompanied by leukocytosis and high serum G-CSF concentrations in the disease progression stage after long-term complete response. We also reviewed previous reports to investigate the clinical behaviors of G-CSF-producing HCC, including our case. Clinicians should consider G-CSF-producing HCC in patients with a hepatic mass and drastic leukocytosis, without any evidence of infection and blood disorders. Early diagnosis and prompt therapy, including radical resection, may provide a more favorable prognosis.Entities:
Keywords: Granulocyte colony-stimulating factor; Hepatocellular carcinoma; Leukocytosis
Mesh:
Substances:
Year: 2020 PMID: 33068269 DOI: 10.1007/s12328-020-01239-9
Source DB: PubMed Journal: Clin J Gastroenterol ISSN: 1865-7265